Literature DB >> 12226837

A review of the terms agglomerate and aggregate with a recommendation for nomenclature used in powder and particle characterization.

Gary Nichols1, Stephen Byard, Mark J Bloxham, Joanne Botterill, Neil J Dawson, Andrew Dennis, Valerie Diart, Nigel C North, John D Sherwood.   

Abstract

The terms "agglomerate" and "aggregate" are widely used by powder technologists to describe assemblages of particles that are found in dry powders and powders in liquid suspensions. Each term has a specific meaning but, unfortunately, they are frequently interchanged at will and this has resulted in universal confusion. This confusion is perpetuated by conflicting definitions in national and international standards and this presents problems when describing powder properties or communicating results in reports and research papers. This paper reviews the current status of the definitions, with particular emphasis on their use in the pharmaceutical industry. It is proposed that just one term, agglomerate, should be used to describe an assemblage of particles in a powder and that the term aggregate should be confined to pre-nucleation structures. Copyright 2002 Wiley-Liss Inc. and the American Pharmaceutical Association

Mesh:

Substances:

Year:  2002        PMID: 12226837     DOI: 10.1002/jps.10191

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  21 in total

1.  Fluidization of nanopowders: a review.

Authors:  J Ruud van Ommen; Jose Manuel Valverde; Robert Pfeffer
Journal:  J Nanopart Res       Date:  2012-02-10       Impact factor: 2.253

Review 2.  Particle size analysis in pharmaceutics: principles, methods and applications.

Authors:  Boris Y Shekunov; Pratibhash Chattopadhyay; Henry H Y Tong; Albert H L Chow
Journal:  Pharm Res       Date:  2006-12-27       Impact factor: 4.200

3.  Investigation of Quantitative X-ray Microscopy for Assessment of API and Excipient Microstructure Evolution in Solid Dosage Processing.

Authors:  Aiden Zhu; Chen Mao; Paul E Luner; Joshua Lomeo; Chi So; Stephanie Marchal; Shawn Zhang
Journal:  AAPS PharmSciTech       Date:  2022-04-19       Impact factor: 3.246

Review 4.  Mechanisms of immune response to inorganic nanoparticles and their degradation products.

Authors:  Raziye Mohammapdour; Hamidreza Ghandehari
Journal:  Adv Drug Deliv Rev       Date:  2021-11-02       Impact factor: 15.470

5.  Experimental Investigation of Thermal Conductivity of Water-Based Fe3O4 Nanofluid: An Effect of Ultrasonication Time.

Authors:  Divya P Barai; Bharat A Bhanvase; Gaweł Żyła
Journal:  Nanomaterials (Basel)       Date:  2022-06-08       Impact factor: 5.719

6.  Wettability Modification of Nanomaterials by Low-Energy Electron Flux.

Authors:  I Torchinsky; G Rosenman
Journal:  Nanoscale Res Lett       Date:  2009-07-02       Impact factor: 4.703

7.  Bacteria can promote calcium oxalate crystal growth and aggregation.

Authors:  Somchai Chutipongtanate; Suchitra Sutthimethakorn; Wararat Chiangjong; Visith Thongboonkerd
Journal:  J Biol Inorg Chem       Date:  2013-01-20       Impact factor: 3.358

8.  Biodistribution of single and aggregated gold nanoparticles exposed to the human lung epithelial tissue barrier at the air-liquid interface.

Authors:  Estelle Durantie; Dimitri Vanhecke; Laura Rodriguez-Lorenzo; Flavien Delhaes; Sandor Balog; Dedy Septiadi; Joel Bourquin; Alke Petri-Fink; Barbara Rothen-Rutishauser
Journal:  Part Fibre Toxicol       Date:  2017-11-29       Impact factor: 9.400

9.  Detecting the oxidative reactivity of nanoparticles: a new protocol for reducing artifacts.

Authors:  Jiayuan Zhao; Michael Riediker
Journal:  J Nanopart Res       Date:  2014-06-28       Impact factor: 2.253

10.  Escherichia coli Aggravates Calcium Oxalate Stone Formation via PPK1/Flagellin-Mediated Renal Oxidative Injury and Inflammation.

Authors:  Lingyue An; Weizhou Wu; Shujue Li; Yongchang Lai; Dong Chen; Zhican He; Zhenglin Chang; Peng Xu; Yapeng Huang; Min Lei; Zheng Jiang; Tao Zeng; Xinyuan Sun; Xuan Sun; Xiaolu Duan; Wenqi Wu
Journal:  Oxid Med Cell Longev       Date:  2021-07-13       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.